» Articles » PMID: 32765791

Identification of the Association Between HMMR Expression and Progression of Hepatocellular Carcinoma Via Construction of a Co-expression Network

Overview
Journal Oncol Lett
Specialty Oncology
Date 2020 Aug 9
PMID 32765791
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to identify key genes involved in the progression of hepatocellular carcinoma (HCC). According to the theory of the multistep process of hepatocarcinogenesis and weighted gene co-expression network analysis, hub genes associated with the progression of HCC were identified using the gene expression profiles of patients with normal to chronic hepatitis/cirrhosis and dysplastic nodules to HCC. An independent dataset was used to verify the association between hub gene and clinical phenotype. The diagnostic and prognostic value of hub genes regarding HCC were evaluated. Gene set enrichment analysis (GSEA) was performed to explore the function of hub genes. A co-expression gene module positively associated with HCC progression was identified. Combined with a protein-protein interaction (PPI) network, a total of 10 common hub genes common to both the module of interest and the PPI network were selected as hub genes. Hyaluronan mediated motility receptor (HMMR) was selected as the candidate gene and was significantly upregulated in HCC at the mRNA and protein expression levels. HMMR is a promising diagnostic biomarker for HCC, and is also associated with its progression. The expression of HMMR was positively correlated with HCC tumor grade, pathological stage, tumor stage and Ishak score. The expression of HMMR was an independent prognostic factor compared with clinicopathological features. Patients with high expression levels of HMMR exhibited a less favorable prognosis. GSEA identified 6 representative gene sets that were associated with cancer. Overall, HMMR may serve an important role in HCC and may have potential as a biomarker of HCC diagnosis and progression.

Citing Articles

Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL.

Ramirez-Chiquito J, Villegas-Ruiz V, Medina-Vera I, Sanchez-Cruz I, Frias-Soria C, Caballero Palacios M Int J Mol Sci. 2025; 26(2).

PMID: 39859458 PMC: 11766256. DOI: 10.3390/ijms26020744.


Comprehensive Analysis Identifies Hyaluronan Mediated Motility Receptor and Cell Division Cycle 25C as Potential Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.

Zhang H, Xu Y, Han H, Ye X, Cheng L, Shen Y Cancer Control. 2024; 31:10732748241287904.

PMID: 39323031 PMC: 11440566. DOI: 10.1177/10732748241287904.


An Efficient Binary Sand Cat Swarm Optimization for Feature Selection in High-Dimensional Biomedical Data.

Pashaei E Bioengineering (Basel). 2023; 10(10).

PMID: 37892853 PMC: 10604175. DOI: 10.3390/bioengineering10101123.


Identification of key genes in bovine muscle development by co-expression analysis.

Zhang J, Sheng H, Pan C, Wang S, Yang M, Hu C PeerJ. 2023; 11:e15093.

PMID: 37070092 PMC: 10105563. DOI: 10.7717/peerj.15093.


HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis.

Shang J, Zhang X, Hou G, Qi Y Front Surg. 2023; 9:998598.

PMID: 36704516 PMC: 9873350. DOI: 10.3389/fsurg.2022.998598.


References
1.
Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T . Prognostic impact of CD168 expression in gastric cancer. BMC Cancer. 2011; 11:106. PMC: 3076262. DOI: 10.1186/1471-2407-11-106. View

2.
Buttermore S, Hoffman M, Kumar A, Champeaux A, Nicosia S, Kruk P . Increased RHAMM expression relates to ovarian cancer progression. J Ovarian Res. 2017; 10(1):66. PMC: 5618727. DOI: 10.1186/s13048-017-0360-1. View

3.
Koelzer V, Huber B, Mele V, Iezzi G, Trippel M, Karamitopoulou E . Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers. Hum Pathol. 2015; 46(11):1573-81. DOI: 10.1016/j.humpath.2015.07.010. View

4.
ISHAK K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F . Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6):696-9. DOI: 10.1016/0168-8278(95)80226-6. View

5.
Pujana M, Han J, Starita L, Stevens K, Tewari M, Ahn J . Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet. 2007; 39(11):1338-49. DOI: 10.1038/ng.2007.2. View